MapLight Therapeutics, Inc.
$28.64
The Read: 7% on average around catalyst events, with price often settling within prior expectations, but it experienced outsized moves up to 37% on positive trial progress updates and notable declines near 9.
Price
Overlays
Panel
MPLT
Hover to view data
No Data